(Q15623825)

English

evolocumab

pharmaceutical drug

AMG-145

In more languages

Statements

type of chemical entity

0 references

chemical compound

0 references

1 reference

Evolocumab (English)

language of work or name

publication date

17 November 2015

defined daily dose

10 milligram

route of administration

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=C10AX13

active ingredient in

1 reference

European Medicines Agency product number

EMEA/H/C/003766

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003766/human_med_001890.jsp

22 March 2017

World Health Organisation international non-proprietary name

evolocumab (English)

1 reference

language of work or name

Evolocumab (English)

19 January 2016

medical condition treated

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

arteriosclerosis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

hyperlipoproteinemia type V

1 reference

Drug Indications Extracted from FAERS

2 October 2018

rare dyslipidemia

1 reference

Drug Indications Extracted from FAERS

2 October 2018

coronary artery disease

1 reference

Drug Indications Extracted from FAERS

2 October 2018

physically interacts with

Proprotein convertase subtilisin/kexin type 9

subject has role

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2364655

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Evolocumab

19 February 2018

0 references

has characteristic

biopharmaceutical

1 reference

Evolocumab (English)

language of work or name

publication date

17 November 2015

subject has role

anticholesteremic agents

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

monoclonal antibody

2 references

language of work or name

Evolocumab (English)

publication date

17 November 2015

27 February 2018

Identifiers

CAS Registry Number

1 reference

language of work or name

Evolocumab (English)

publication date

17 November 2015

1 reference

language of work or name

Evolocumab (English)

19 January 2016

1 reference

Hazardous Substances Data Bank

publication date

28 October 2019

Evolocumab (English)

10 May 2021

0 references

1 reference

language of work or name

Evolocumab (English)

publication date

17 November 2015

World Health Organisation international non-proprietary name numeric ID

0 references

Guide to Pharmacology Ligand ID

0 references

MeSH descriptor ID

subject named as

evolocumab

1 reference

Medical Subject Headings

MeSH descriptor ID

14 March 2018

1 reference

26 February 2018

2 references

language of work or name

Evolocumab (English)

publication date

17 November 2015

https://www.drugbank.ca/releases/latest#open-data

April 2018

1 reference

language of work or name

EVOLOCUMAB (English)

19 January 2016

MedlinePlus drug identifier

0 references

1 reference

language of work or name

EVOLOCUMAB (English)

19 January 2016

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(14 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q15623825&oldid=2139648809"